Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

Gynecologic Oncology

Volumn 110, Issue 2, 2008, Pages 133-139

  Moore, Kathleen N ^a   Reid, Monica S ^a   Fong, Daniel N ^a   Myers, Tashanna K N ^a   Landrum, Lisa M ^a   Moxley, Katherine M ^a   Walker, Joan L ^a   McMeekin, D Scott ^a   Mannel, Robert S ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Complications; Elderly; Gero oncology; Ovarian cancer

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; PLATINUM DERIVATIVE;

ABDOMINAL PAIN; ADVANCED CANCER; AGED; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; CONSTIPATION; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DEPRESSION; DIARRHEA; DRUG DOSE REDUCTION; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEART DISEASE; HUMAN; ILEUS; LUNG DISEASE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVARY CANCER; PARESTHESIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURGICAL WOUND; THROMBOCYTOPENIA; TINNITUS; UNSPECIFIED SIDE EFFECT; VOMITING;

AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARRHYTHMIAS, CARDIAC; CHEMOTHERAPY, ADJUVANT; COMORBIDITY; CYCLOPHOSPHAMIDE; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PACLITAXEL; RETROSPECTIVE STUDIES;

EID: 47249098907     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.03.008     Document Type: Article

References (30)

1. American Cancer Society. Cancer facts and figures 2007 (2007), American Cancer Society, Atlanta
2. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site 2006.
3. Magtibay P.M., Adams P.B., Silverman M.B., et al. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 102 (2006) 369-374
4. Bristow R.E., Months F.J., Legasse L.D., et al. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 72 (1999) 278-287
5. Merideth M., Cliba W., Keeney G., et al. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol 89 (2003) 16-21
6. Chi D.S., Franklin C.C., Levine D.A., et al. Improved optimal cytoreduction rates for stage IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94 (2004) 650-654
7. Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 103 (2006) 1083-1090
8. Aletti G.D., Dowdy S.C., Podratz K.C., et al. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 100 (2006) 283-287
9. Aletti G., Dowdy S.C., Gostout B.S., et al. Aggressive surgical effort and improved survival in advanced stage ovarian cancer. Obstet Gynecol 107 (2006) 77-85
10. Armstrong D.K., Bundy B., Wenzel L., et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. NEJM 354 1 (2006) 34-43
11. Oriel K.A., Hartenbach E.M., and Remington P.L. Trends in United States ovarian cancer mortality, 1975-1995. Obstet Gynecol 93 (1999) 30-33
12. Thigpen T., Brady M.F., Omura G.A., et al. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer 71 (1993) 606-614
13. Maas H.A., Kruitwagen R.F., Lemmens V.E., et al. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population based study. Gynecol Oncol 97 (2005) 104-109
14. Markman M., Lewis Jr. J.L., Saigo P., et al. Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience. Cancer 71 (1993) 634-637
15. Ries L.A. Ovarian cancer. Survival and treatment differences by age. Cancer 71 (1993) 524-529
16. Hightower R.D., Nguyen H.N., Averette H.E., et al. National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients. Cancer 73 (1994) 377-383
17. Cloven N.G., Manetta A., Berman M.L., et al. Management of ovarian cancer in patients older than 80 years of age. Gynecol Oncol 73 (1999) 137-139
18. Sundararajan V., Hershman D., Grann V.R., et al. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population based study. J Clin Oncol 20 (2002) 173-178
19. Uyar D., Frasure H.E., Markman M., et al. Treatment patterns by decade of life in elderly women with ovarian cancer. Gynecol Oncol 98 (2005) 403-408
20. Marchetti D.L., Lele S.B., Priore R.L., et al. Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol 49 (1993) 86-91
21. Diaz-Montes T.P., Zahurak M.L., Giuntoli R.L., et al. Surgical care of elderly women with ovarian cancer: a population based perspective. Gynecol Oncol 99 (2005) 352-357
22. Cascinu S., Del Ferro E., and Catalano G. Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer. Am J Clin Oncol 19 (1996) 371-374
23. Wright J.D., Herzog T.J., and Powell M.A. Morbidity of cytoreductive surgery in the elderly. Am J Clin Oncol 190 (2004) 1398-1400
24. Sharma S., Driscoll D., Odunsi K., et al. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol 193 (2005) 2077-2082
25. Ben-Ami I., Vaknin Z., Schneider D., et al. Perioperative morbidity and mortality of gynecological oncologic surgery in elderly women. Int J Gynecol Cancer 16 (2006) 452-457
26. Dixon D.O., Neilan B., Jones S.E., et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol 4 3 (1986) 295-305
27. Rocha-Lima C.M., Herndon J.E., Kosty M., et al. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B. Cancer 94 1 (2002) 181-187
28. von Gruenigen V. Clinical trials in the elderly (July 2006), Presented at the Gynecologic Group Meeting Symposium, Washington D.C.
29. Balducci L., and Extermann M. Management of cancer in the older person: a practical approach. Oncologist 5 3 (2000) 224-237
30. Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 55 3 (2005) 241-252